- Home
- MCVT vs CLDI Comparison
MCVT vs CLDI Comparison
Compare MCVT & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCVT
- CLDI
- Stock Information
- Founded
- MCVT 2007
- CLDI 2014
- Country
- MCVT United States
- CLDI United States
- Employees
- MCVT N/A
- CLDI N/A
- Industry
- MCVT Finance Companies
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MCVT Finance
- CLDI Health Care
- Exchange
- MCVT Nasdaq
- CLDI Nasdaq
- Market Cap
- MCVT 9.3M
- CLDI 10.2M
- IPO Year
- MCVT N/A
- CLDI N/A
- Fundamental
- Price
- MCVT $1.84
- CLDI $0.23
- Analyst Decision
- MCVT
- CLDI Strong Buy
- Analyst Count
- MCVT 0
- CLDI 1
- Target Price
- MCVT N/A
- CLDI $10.00
- AVG Volume (30 Days)
- MCVT 16.2K
- CLDI 1.8M
- Earning Date
- MCVT 08-13-2025
- CLDI 08-12-2025
- Dividend Yield
- MCVT N/A
- CLDI N/A
- EPS Growth
- MCVT N/A
- CLDI N/A
- EPS
- MCVT 0.19
- CLDI N/A
- Revenue
- MCVT $3,246,479.00
- CLDI N/A
- Revenue This Year
- MCVT N/A
- CLDI N/A
- Revenue Next Year
- MCVT N/A
- CLDI N/A
- P/E Ratio
- MCVT $9.81
- CLDI N/A
- Revenue Growth
- MCVT N/A
- CLDI N/A
- 52 Week Low
- MCVT $1.13
- CLDI $0.20
- 52 Week High
- MCVT $3.88
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- MCVT 50.24
- CLDI 21.13
- Support Level
- MCVT $1.77
- CLDI $0.31
- Resistance Level
- MCVT $1.91
- CLDI $0.33
- Average True Range (ATR)
- MCVT 0.08
- CLDI 0.04
- MACD
- MCVT -0.01
- CLDI -0.01
- Stochastic Oscillator
- MCVT 36.11
- CLDI 14.83
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.